Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Intravenous Iron Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Intravenous Iron Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Intravenous Iron Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
NOXXON Pharma
Galenica
Allergan
Wanbang Biopharmaceutical
AMAG Pharmaceuticals
Nippon Shinyaku
Pharmacosmos
Rockwell Medical
Daiichi Sankyo
Sanofi
By Type:
Ferric carboxy maltose
Sucrose
Dextran
By End-User:
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous Iron Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Intravenous Iron Drugs Market Size and Growth Rate of Ferric carboxy maltose from 2016 to 2027
-
1.3.2 China Intravenous Iron Drugs Market Size and Growth Rate of Sucrose from 2016 to 2027
-
1.3.3 China Intravenous Iron Drugs Market Size and Growth Rate of Dextran from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Intravenous Iron Drugs Market Size and Growth Rate of Nephrology from 2016 to 2027
-
1.4.2 China Intravenous Iron Drugs Market Size and Growth Rate of Gynecology & Obstetrics from 2016 to 2027
-
1.4.3 China Intravenous Iron Drugs Market Size and Growth Rate of Gastroenterology from 2016 to 2027
-
1.4.4 China Intravenous Iron Drugs Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.5 China Intravenous Iron Drugs Market Size and Growth Rate of Cardiology from 2016 to 2027
-
1.4.6 China Intravenous Iron Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Intravenous Iron Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Intravenous Iron Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Ferric carboxy maltose
-
3.4.2 Market Size and Growth Rate of Sucrose
-
3.4.3 Market Size and Growth Rate of Dextran
4 Segmentation of Intravenous Iron Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Intravenous Iron Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Intravenous Iron Drugs in Nephrology
-
4.4.2 Market Size and Growth Rate of Intravenous Iron Drugs in Gynecology & Obstetrics
-
4.4.3 Market Size and Growth Rate of Intravenous Iron Drugs in Gastroenterology
-
4.4.4 Market Size and Growth Rate of Intravenous Iron Drugs in Oncology
-
4.4.5 Market Size and Growth Rate of Intravenous Iron Drugs in Cardiology
-
4.4.6 Market Size and Growth Rate of Intravenous Iron Drugs in Others
5 Market Analysis by Regions
-
5.1 China Intravenous Iron Drugs Production Analysis by Regions
-
5.2 China Intravenous Iron Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Intravenous Iron Drugs Landscape Analysis
-
6.1 North China Intravenous Iron Drugs Landscape Analysis by Major Types
-
6.2 North China Intravenous Iron Drugs Landscape Analysis by Major End-Users
7 Central China Intravenous Iron Drugs Landscape Analysis
-
7.1 Central China Intravenous Iron Drugs Landscape Analysis by Major Types
-
7.2 Central China Intravenous Iron Drugs Landscape Analysis by Major End-Users
8 South China Intravenous Iron Drugs Landscape Analysis
-
8.1 South China Intravenous Iron Drugs Landscape Analysis by Major Types
-
8.2 South China Intravenous Iron Drugs Landscape Analysis by Major End-Users
9 East China Intravenous Iron Drugs Landscape Analysis
-
9.1 East China Intravenous Iron Drugs Landscape Analysis by Major Types
-
9.2 East China Intravenous Iron Drugs Landscape Analysis by Major End-Users
10 Northeast China Intravenous Iron Drugs Landscape Analysis
-
10.1 Northeast China Intravenous Iron Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Intravenous Iron Drugs Landscape Analysis by Major End-Users
11 Southwest China Intravenous Iron Drugs Landscape Analysis
-
11.1 Southwest China Intravenous Iron Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Intravenous Iron Drugs Landscape Analysis by Major End-Users
12 Northwest China Intravenous Iron Drugs Landscape Analysis
-
12.1 Northwest China Intravenous Iron Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Intravenous Iron Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 NOXXON Pharma
-
13.1.1 NOXXON Pharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Galenica
-
13.2.1 Galenica Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Allergan
-
13.3.1 Allergan Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Wanbang Biopharmaceutical
-
13.4.1 Wanbang Biopharmaceutical Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 AMAG Pharmaceuticals
-
13.5.1 AMAG Pharmaceuticals Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Nippon Shinyaku
-
13.6.1 Nippon Shinyaku Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Pharmacosmos
-
13.7.1 Pharmacosmos Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Rockwell Medical
-
13.8.1 Rockwell Medical Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Daiichi Sankyo
-
13.9.1 Daiichi Sankyo Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Sanofi
-
13.10.1 Sanofi Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Ferric carboxy maltose from 2016 to 2027
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Sucrose from 2016 to 2027
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Dextran from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Nephrology from 2016 to 2027
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Gynecology & Obstetrics from 2016 to 2027
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Gastroenterology from 2016 to 2027
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Cardiology from 2016 to 2027
-
Figure China Intravenous Iron Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Intravenous Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Intravenous Iron Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Intravenous Iron Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Intravenous Iron Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Intravenous Iron Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Ferric carboxy maltose
-
Figure Market Size and Growth Rate of Sucrose
-
Figure Market Size and Growth Rate of Dextran
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Intravenous Iron Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Intravenous Iron Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Nephrology
-
Figure Market Size and Growth Rate of Gynecology & Obstetrics
-
Figure Market Size and Growth Rate of Gastroenterology
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Cardiology
-
Figure Market Size and Growth Rate of Others
-
Table China Intravenous Iron Drugs Production by Regions
-
Table China Intravenous Iron Drugs Production Share by Regions
-
Figure China Intravenous Iron Drugs Production Share by Regions in 2016
-
Figure China Intravenous Iron Drugs Production Share by Regions in 2021
-
Figure China Intravenous Iron Drugs Production Share by Regions in 2027
-
Table China Intravenous Iron Drugs Consumption by Regions
-
Table China Intravenous Iron Drugs Consumption Share by Regions
-
Figure China Intravenous Iron Drugs Consumption Share by Regions in 2016
-
Figure China Intravenous Iron Drugs Consumption Share by Regions in 2021
-
Figure China Intravenous Iron Drugs Consumption Share by Regions in 2027
-
Table North China Intravenous Iron Drugs Consumption by Types from 2016 to 2027
-
Table North China Intravenous Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Intravenous Iron Drugs Consumption Share by Types in 2016
-
Figure North China Intravenous Iron Drugs Consumption Share by Types in 2021
-
Figure North China Intravenous Iron Drugs Consumption Share by Types in 2027
-
Table North China Intravenous Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Intravenous Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Intravenous Iron Drugs Consumption Share by End-Users in 2016
-
Figure North China Intravenous Iron Drugs Consumption Share by End-Users in 2021
-
Figure North China Intravenous Iron Drugs Consumption Share by End-Users in 2027
-
Table Central China Intravenous Iron Drugs Consumption by Types from 2016 to 2027
-
Table Central China Intravenous Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Intravenous Iron Drugs Consumption Share by Types in 2016
-
Figure Central China Intravenous Iron Drugs Consumption Share by Types in 2021
-
Figure Central China Intravenous Iron Drugs Consumption Share by Types in 2027
-
Table Central China Intravenous Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Intravenous Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Intravenous Iron Drugs Consumption Share by End-Users in 2016
-
Figure Central China Intravenous Iron Drugs Consumption Share by End-Users in 2021
-
Figure Central China Intravenous Iron Drugs Consumption Share by End-Users in 2027
-
Table South China Intravenous Iron Drugs Consumption by Types from 2016 to 2027
-
Table South China Intravenous Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Intravenous Iron Drugs Consumption Share by Types in 2016
-
Figure South China Intravenous Iron Drugs Consumption Share by Types in 2021
-
Figure South China Intravenous Iron Drugs Consumption Share by Types in 2027
-
Table South China Intravenous Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Intravenous Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Intravenous Iron Drugs Consumption Share by End-Users in 2016
-
Figure South China Intravenous Iron Drugs Consumption Share by End-Users in 2021
-
Figure South China Intravenous Iron Drugs Consumption Share by End-Users in 2027
-
Table East China Intravenous Iron Drugs Consumption by Types from 2016 to 2027
-
Table East China Intravenous Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Intravenous Iron Drugs Consumption Share by Types in 2016
-
Figure East China Intravenous Iron Drugs Consumption Share by Types in 2021
-
Figure East China Intravenous Iron Drugs Consumption Share by Types in 2027
-
Table East China Intravenous Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Intravenous Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Intravenous Iron Drugs Consumption Share by End-Users in 2016
-
Figure East China Intravenous Iron Drugs Consumption Share by End-Users in 2021
-
Figure East China Intravenous Iron Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Intravenous Iron Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Intravenous Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Intravenous Iron Drugs Consumption Share by Types in 2016
-
Figure Northeast China Intravenous Iron Drugs Consumption Share by Types in 2021
-
Figure Northeast China Intravenous Iron Drugs Consumption Share by Types in 2027
-
Table Northeast China Intravenous Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Intravenous Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Intravenous Iron Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Intravenous Iron Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Intravenous Iron Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Intravenous Iron Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Intravenous Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Intravenous Iron Drugs Consumption Share by Types in 2016
-
Figure Southwest China Intravenous Iron Drugs Consumption Share by Types in 2021
-
Figure Southwest China Intravenous Iron Drugs Consumption Share by Types in 2027
-
Table Southwest China Intravenous Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Intravenous Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Intravenous Iron Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Intravenous Iron Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Intravenous Iron Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Intravenous Iron Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Intravenous Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Intravenous Iron Drugs Consumption Share by Types in 2016
-
Figure Northwest China Intravenous Iron Drugs Consumption Share by Types in 2021
-
Figure Northwest China Intravenous Iron Drugs Consumption Share by Types in 2027
-
Table Northwest China Intravenous Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Intravenous Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Intravenous Iron Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Intravenous Iron Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Intravenous Iron Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of NOXXON Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NOXXON Pharma
-
Figure Sales and Growth Rate Analysis of NOXXON Pharma
-
Figure Revenue and Market Share Analysis of NOXXON Pharma
-
Table Product and Service Introduction of NOXXON Pharma
-
Table Company Profile and Development Status of Galenica
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galenica
-
Figure Sales and Growth Rate Analysis of Galenica
-
Figure Revenue and Market Share Analysis of Galenica
-
Table Product and Service Introduction of Galenica
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Wanbang Biopharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wanbang Biopharmaceutical
-
Figure Sales and Growth Rate Analysis of Wanbang Biopharmaceutical
-
Figure Revenue and Market Share Analysis of Wanbang Biopharmaceutical
-
Table Product and Service Introduction of Wanbang Biopharmaceutical
-
Table Company Profile and Development Status of AMAG Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AMAG Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of AMAG Pharmaceuticals
-
Figure Revenue and Market Share Analysis of AMAG Pharmaceuticals
-
Table Product and Service Introduction of AMAG Pharmaceuticals
-
Table Company Profile and Development Status of Nippon Shinyaku
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nippon Shinyaku
-
Figure Sales and Growth Rate Analysis of Nippon Shinyaku
-
Figure Revenue and Market Share Analysis of Nippon Shinyaku
-
Table Product and Service Introduction of Nippon Shinyaku
-
Table Company Profile and Development Status of Pharmacosmos
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmacosmos
-
Figure Sales and Growth Rate Analysis of Pharmacosmos
-
Figure Revenue and Market Share Analysis of Pharmacosmos
-
Table Product and Service Introduction of Pharmacosmos
-
Table Company Profile and Development Status of Rockwell Medical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rockwell Medical
-
Figure Sales and Growth Rate Analysis of Rockwell Medical
-
Figure Revenue and Market Share Analysis of Rockwell Medical
-
Table Product and Service Introduction of Rockwell Medical
-
Table Company Profile and Development Status of Daiichi Sankyo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo
-
Table Product and Service Introduction of Daiichi Sankyo
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
